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This article reviews microneurographic research on sympathetic neural control in
women under both physiological and pathophysiological conditions across the lifespan.
Specifically, the effects of sex, age, race, the menstrual cycle, oral contraceptives,
estrogen replacement therapy, and normal pregnancy on neural control of blood pressure
in healthy women are reviewed. In addition, sympathetic neural activity during neurally
mediated (pre)syncope, the Postural Orthostatic Tachycardia Syndrome (POTS), obesity,
the Polycystic Ovary Syndrome (PCOS), gestational hypertension, and preeclampsia,
chronic essential hypertension, heart failure, and myocardial infarction in women are
also reviewed briefly. It is suggested that microneurographic studies provide valuable
information regarding autonomic circulatory control in women of different ages and
in most cases, excessive sympathetic activation is associated with specific medical
conditions regardless of age and sex. In some situations, sympathetic inhibition or
withdrawal may be the underlying mechanism. Information gained from previous and
recent microneurographic studies has significant clinical implications in women’s health,
and in some cases could be used to guide therapy if more widely available.
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INTRODUCTION
Microneurography was developed in themid-1960s in Sweden for
percutaneous recordings of action potentials in human peripheral
nerves (i.e., tibial, peroneal, median, or radial nerve), mostly in
groups of sympathetic fibers (multiunit activity) but also in sin-
gle axons (single-unit activity) (Wallin, 2012). In this review, we
only focus on multiunit recordings. By using this technique, post-
ganglionic efferent nerve discharges leading to the skeletal muscle
(the muscular bed), which is called muscle sympathetic nerve
activity (MSNA) can be recorded (Wallin et al., 1974). Criteria for
adequateMSNA recordings include (1) pulse synchrony; (2) facil-
itation during the hypotensive phase of the Valsalva maneuver,
and suppression during the hypertensive overshoot after release;
(3) increases in response to breath holding; and (4) insensi-
tivity to emotional stimuli (Wallin et al., 1974). The number
of sympathetic bursts per minute (burst frequency), the num-
ber of bursts per 100 heart beats (burst incidence), and the
number of bursts multiplied by mean burst area of the integrated
neurogram (total activity) are used as quantitative indexes (Vallbo
et al., 1979; Halliwill, 2000; Wallin, 2012). The advantages and
limitations of microneurography have previously been reviewed
(Wallin and Charkoudian, 2007).
Over the past 20 years or so, microneurographic studies have
been performed in women of different ages under various physio-
logical and pathophysiological conditions.Microneurography has
become a potent and useful tool in clinical autonomic function
assessment (Mano et al., 2006). Information gained from previ-
ous and recent microneurographic research has helped us better
understand sympathetic neural mechanisms in women’s health
and disease.
PHYSIOLOGICAL CONDITIONS
IMPACTS OF SEX AND AGE ON MSNA
There are sex and age-related differences in the prevalence of
hypertension and cardiovascular disease in humans. One of the
important determinants for these differences is sympathetic neu-
ral control. Numerous studies have indicated that sex and/or
age affect sympathetic neural activity at rest or during perturba-
tions. For example, basal MSNA has been found to be lower in
young women compared to young men (Matsukawa et al., 1998b;
Narkiewicz et al., 2005). MSNA increases with age, and the incre-
ment is greater in women than in men (Iwase et al., 1991; Ebert
et al., 1992; Fagius and Wallin, 1993; Matsukawa et al., 1998b;
Narkiewicz et al., 2005). Therefore, elderly women have a similar
or greater basal MSNA and a greater increase in arterial pressure
for a given increase in MSNA than elderly men (Matsukawa et al.,
1998b; Narkiewicz et al., 2005; Studinger et al., 2009; Hart et al.,
2011; Okada et al., 2012b) (Figure 1). The latter may be one of
the mechanisms for sex differences in hypertension in seniors (Fu
et al., 2008b).
Baroreflex control of MSNA or sympathetic baroreflex sensi-
tivity has been reported to be similar between young men and
women (Tank et al., 2005; Fu et al., 2009; Studinger et al., 2009;
Hart et al., 2011). With women of more advanced age, sympa-
thetic baroreflex sensitivity remains unchanged (Ebert et al., 1992;
Studinger et al., 2009) or decreases (Matsukawa et al., 1998a; Hart
et al., 2011). A recent study showed that sympathetic baroreflex
sensitivity was lower in elderly women than elderly men, which
was associated with greater arterial stiffness in women (Okada
et al., 2012b), perhaps leading to less baroreceptor distortion for
a given pressure pulse.
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FIGURE 1 | Resting muscle sympathetic nerve activity increases with
age and the increment is greater in women than in men. Adapted with
permission from Matsukawa et al. (1998b).
Studies regarding the effects of sex on sympathetic neural
responses during orthostasis are few and the results are incon-
sistent; similar (Fu et al., 2005, 2009) or attenuated (Shoemaker
et al., 2001)MSNA responses have been reported in youngwomen
compared to young men. One explanation for these inconsistent
findings may be the impact of the menstrual cycle. Two of the
three studies (Shoemaker et al., 2001; Fu et al., 2005) did not con-
trol for menstrual phases in female subjects. It was found that
women during menstruation (i.e., the early follicular phase, low
estrogen and progesterone) tended to have smaller increases in
MSNA total activity (P = 0.102 for sex) but similar increases in
burst frequency during orthostasis compared to men; however,
these differences were small and not statistically robust (Fu et al.,
2009) (Figure 2).
With regard to other well characterized stimuli such as
static handgrip, similar (Jones et al., 1996b) or attenuated
(Ettinger et al., 1996; Jarvis et al., 2011) MSNA responses
have been reported in young women than young men. Jones
et al. found that women and men responded with compara-
ble increases in MSNA during 1min of handgrip (Jones et al.,
1996b). However, a common metabolic endpoint (i.e., fatigue)
is necessary for comparisons between the sexes and/or age.
Recent work from our laboratory showed that young women
demonstrated attenuated increases in MSNA during static hand-
grip to fatigue and post-exercise circulatory arrest, indicating
a blunted metaboreflex (Jarvis et al., 2011). Conversely, dur-
ing a cold pressor test, heart rate and MSNA responses were
similar in men and women, suggesting that central integra-
tion and the efferent pathway were comparable between the
sexes (Jones et al., 1996b; Jarvis et al., 2011). During men-
tal stress, young women demonstrated a smaller increase in
arterial pressure than young men, but changes in MSNA and
heart rate were not different between the sexes (Carter and Ray,
2009).
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FIGURE 2 | Muscle sympathetic nerve activity (MSNA) burst frequency
(A) and total activity (B) responses during a graded upright tilt in men
and women during the early follicular phase (when both estrogen and
progesterone are low) and the mid-luteal phase (when both sex
hormones are high). Values are means ± S.E.M. Tilt5, Tilt10, Tilt20, Tilt30,
Tilt40, and Tilt45, 5, 10, 20, 30, 40, and 45min after 60◦ upright tilt. Adapted
with permission from Fu et al. (2009).
Taken together, sympathetic neural control can be affected by
sex and/or age in humans. Young women during menstruation
tend to have attenuated increases in MSNA total activity but
not burst frequency during orthostasis as compared to young
men, while these differences are not statistically robust. On the
other hand, young women have a blunted exercise pressor reflex,
which may protect them from developing hypertension and car-
diovascular disease. It should be noted that the MSNA differ-
ence between men and women is much smaller than the range
of MSNA observed in healthy individuals (Wallin et al., 1993;
Charkoudian et al., 2005; Wallin, 2007; Joyner et al., 2010). Thus,
the influences of genes, age, or other factors may be much greater
when compared to a sex effect. The greater age-related increase in
basal MSNA and decrease in baroreflex function may be respon-
sible for the high prevalence of hypertension and cardiovascular
disease in elderly women.
RACIAL DIFFERENCES IN MSNA
Black women have a higher prevalence of hypertension compared
to white women (Burt et al., 1995), which may be due to
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racial differences in sympathetic neural control of blood pres-
sure. It was previously found that physiological or psychological
stressors increased MSNA more in young blacks than in young
whites (Calhoun, 1992; Calhoun et al., 1993), especially in those
with a family history of hypertension (Calhoun and Mutinga,
1997). Conversely, some investigators showed that there were
no significant differences in basal or stimulated norepinephrine
spillover between young blacks and whites (Stein et al., 2000).
Ray et al. found that compared to young whites, young blacks
had lower MSNA responses but similar vasoconstriction during
orthostatic stress, indicating an enhanced sympathetic vascular
transduction in blacks (Ray andMonahan, 2002). Consistent with
the study of Ray et al., we recently found that elderly blacks had
a blunted sympathetic neural responsiveness but greater pressor
response during orthostasis compared with elderly whites (Okada
et al., 2012a). However, sex was not investigated in this study.
Although at rest young lean black men were found to have
a greater MSNA than white men, basal MSNA was similar
between young black and white women (Abate et al., 2001). In
black women, adiposity seems to be a major determinant of
sympathetic discharge (Abate et al., 2001). It is possible that
black women have enhanced sympathetic neural responses and/or
sympathetic adrenergically medicated vasoconstriction during
perturbations compared to white women, which may be the
mechanisms for the higher prevalence of hypertension in this
population.
Racial differences in sympathetic neural control in women
have not been investigated extensively. There is no clear synthesis
possible at this time.
MENSTRUAL CYCLE EFFECTS AND ORAL CONTRACEPTIVES IN
PREMENOPAUSALWOMEN
Results regarding the effects of the menstrual cycle on
sympathetic neural control in healthy young women are
controversial. Some (Minson et al., 2000a; Park and Middlekauff,
2009) but not all (Jones et al., 1996b; Carter et al., 2009; Fu
et al., 2009; Jarvis et al., 2011) investigators have reported that
the fluctuations of female sex hormones during the menstrual
cycle may affect basal MSNA and sympathetic baroreflex sen-
sitivity at supine rest in women. Two studies have uniformly
demonstrated that themenstrual cycle can affectMSNA responses
during orthostasis (Carter et al., 2009; Fu et al., 2009). For exam-
ple, it was found that an increase in MSNA total activity during
upright tilt (Fu et al., 2009) and lower body negative pressure
(Carter et al., 2009) was smaller in the early follicular phase (day
1–5 after the onset of menstruation, low estrogen and proges-
terone) than in the mid-luteal phase (day 19–22, high estrogen
and progesterone). However, both studies showed that the men-
strual cycle did not influence sympathetic baroreflex sensitivity
responses during orthostatic stress (Carter et al., 2009; Fu et al.,
2009). On the other hand, MSNA responses during static hand-
grip (Minson et al., 2000a; Jarvis et al., 2011), mental stress
(Carter and Lawrence, 2007), and vestibulosympathetic stimula-
tion (Lawrence et al., 2008) were all similar between menstrual
phases.
To date, there are only two studies published regarding the
effects of oral contraceptives on sympathetic neural control
in young women. Minson et al. previously showed that oral
contraceptive use did not affect basal MSNA, but it affected
resting sympathetic baroreflex sensitivity (Minson et al., 2000b).
Furthermore, the authors found that changes in baroreflex sensi-
tivity with oral contraceptive use differed from changes in barore-
flex sensitivity during the normal menstrual cycle (Minson et al.,
2000b). Conversely, Carter et al. showed that oral contraceptives
did not alter cardiovascular and sympathetic neural responses to
an orthostatic challenge in young healthy women (Carter et al.,
2010). Whether similar observations can be made during other
perturbations such as the cold pressor test andmental stress needs
to be determined.
Taken together, recent studies have shown that the menstrual
cycle can affect MSNA total activity responses during orthostatic
stress, and women during the early follicular phase have attenu-
ated upright total activity. However, sympathetic neural responses
during static handgrip, mental stress, and vestibulosympathetic
stimulation are not influenced by the menstrual cycle. Oral con-
traceptives appear to have limited impact on sympathetic neural
control in young women. Further research is needed to confirm
these findings.
IMPACTS OF ESTROGEN REPLACEMENT THERAPY ON MSNA IN
POSTMENOPAUSALWOMEN
Menopausal estrogen loss is associated with an increased
risk for cardiovascular events in women (Burt et al., 1995).
Supplemental estrogen has been proposed to reverse, to some
extent, deficits in blood pressure control and protect against
the development of hypertension and cardiovascular disease in
postmenopausal women (Hunt et al., 2001). However, the ther-
apeutic effects of estrogen supplementation may be influenced
by the dosage, the type of estrogen used, the duration of treat-
ment (i.e., acute versus chronic) and/or the route of admin-
istration (i.e., transdermal versus oral). For example, low-dose
estrogen replacement therapy was found to be not effective
in decreasing MSNA and blood pressure in postmenopausal
women (Oneda et al., 2008). Transdermal administration of
estrogen supplement suppressed basal MSNA without augment-
ing arterial baroreflexes, and sympathetic inhibition was evident
only with chronic rather than acute estrogen administration
(Vongpatanasin et al., 2001; Weitz et al., 2001). Conversely, oral
administration of estrogen does not change basal levels of MSNA
(Hunt et al., 2001; Vongpatanasin et al., 2001; Moreau et al.,
2003).
These studies suggest that chronic transdermal administration
of estrogen supplement at a high dosage may be necessary in the
restoration of the deficits in sympathetic neural control of blood
pressure in postmenopausal women.
SYMPATHETIC NEURAL CONTROL DURING NORMAL
PREGNANCY
Normal pregnancy is associated with dramatic changes in hemo-
dynamics, which occur through autonomic control mecha-
nisms (Ekholm et al., 1994; Fu and Levine, 2009). Earlier
human studies on sympathetic activity during pregnancy focused
only on plasma norepinephrine concentrations, which ranged
from increased to decreased compared with non-pregnant
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conditions (Zuspan, 1979; Tunbridge and Donnai, 1981; Barron
et al., 1986; Chapman et al., 1998). With microneurography,
Greenwood et al. found that basal MSNA increased in normoten-
sive pregnant women during the third trimester of gestation
(Greenwood et al., 1998, 2001). A decrease in baroreceptor-
mediated inhibitory restraint on central sympathetic outflow
may be one potential explanation for these findings. It is also
possible that changes in hormonal factors associated with preg-
nancy may cause sympathetic activation. Greenwood et al.
followed three normotensive pregnant women 6 weeks after
delivery and found that sympathetic activity decreased dramat-
ically (Greenwood et al., 1998). Their preliminary data indicate
that the end of normal pregnancy may be associated with an
increase in resting sympathetic outflow and pregnancy per se
may result in sympathetic activation despite a normal blood
pressure.
We recently found that basal MSNA and MSNA in the upright
posture were markedly greater, while diastolic pressure was lower
and peripheral vascular resistance decreased during early preg-
nancy (i.e., ≤ 8 weeks of gestation) compared to pre-pregnancy
in healthy young women (Jarvis et al., 2012). These results
suggest that sympathetic activation may be a common char-
acteristic of early pregnancy in humans. These observations
challenge conventional thinking about blood pressure regulation
during pregnancy, which suggests that sympathetic activation
occurs only at the end of pregnancy, and to our knowledge,
there are no published sympathetic nerve recordings during
early pregnancy in humans. Our study has shown that marked
sympathetic activation occurs within the first few weeks of con-
ception, and may provide the substrate for pregnancy induced
cardiovascular complications. If we confirm that women with
hypertensive disorders of pregnancy have a greater increase in
MSNA or sympathetic vasoconstriction early on during preg-
nancy when compared to women with normotensive pregnancies,
we could make an early diagnosis or prediction. Early preven-
tion or treatment targeted to the appropriate pathophysiology
may be initiated, which may reduce maternal and fetal death
or morbidity, as well as cardiovascular risks in women later in
life.
Taken together, sympathetic activation is a common phe-
nomenon during normal pregnancy in healthy women, which
occurs as early as 4 weeks of gestation, remaining high throughout
the entire pregnancy. It may represent a compensatory mecha-
nism induced by peripheral vasodilation; in addition, alterations
in hormonal factors associated with pregnancy may also con-
tribute to sympathetic activation in pregnant women.
PATHOPHYSIOLOGICAL CONDITIONS
SYNCOPE AND SYMPATHETICWITHDRAWAL
Syncope is a common clinical condition affecting up to 40%
of otherwise healthy people (Ganzeboom et al., 2006; Serletis
et al., 2006), especially young women (Robertson, 1999; Fu
et al., 2004). Based on current conventional wisdom, loss of
sympathetic tone (Wallin and Sundlof, 1982; Dietz et al., 1997;
Morillo et al., 1997; Mosqueda-Garcia et al., 1997) with relax-
ation of vascular resistance (Lewis, 1932; Barcroft et al., 1944;
Weissler et al., 1957; Epstein et al., 1968) is thought to play
a major role in neurally mediated syncope. However, Cooke
et al. reported that withdrawal of MSNA was not a prerequisite
for (pre)syncope despite significant decreases of arterial pres-
sure in healthy individuals (Cooke et al., 2009). We recently
showed that MSNA decreased rapidly at presyncope often after
the onset of hypotension, while a moderate fall in cardiac
output with coincident vasodilation or a marked fall in car-
diac output with no changes in peripheral vascular resistance
may contribute to (pre)syncope (Fu et al., 2012). Blood pres-
sure and MSNA responses in the development of presyncope
seem to be similar between young men and young women,
as well as between menstrual phases in women (Fu et al.,
2009).
In a retrospective study in healthy young individuals with-
out manifest cardiovascular disease, we found that approximately
10–15% of the presyncopal subjects (all females) had no sig-
nificant decreases in MSNA prior to presyncope, while these
subjects appeared to have greater increases in plasma epinephrine
concentration (Fu et al., 2008a), suggesting that stimulation of β2-
adrenergic receptors without changes in vasomotor sympathetic
activity may also elicit (pre)syncope in humans, though this must
be tested in a prospective design.
Taken together, sympathetic withdrawal at (pre)syncope
occurs in the majority of healthy people without manifest
cardiovascular disease. In a small subset, stimulation of β2-
adrenergic receptors without sympathetic withdrawal may elicit
(pre)syncope. Recent findings suggest that sympathetic with-
drawalmay not be a prerequisite for (pre)syncope, becauseMSNA
decreases rapidly at presyncope after the onset of hypotension. A
moderate fall in cardiac output with coincident vasodilation or
a marked fall in cardiac output with no changes in peripheral
vascular resistance may contribute to (pre)syncope in this pop-
ulation. These patterns may uncover distinct patient populations
with different mechanisms and could be a target for pathophysi-
ology specific therapy if borne out in clinical trials.
NEURAL CONTROL IN THE POSTURAL ORTHOSTATIC
TACHYCARDIA SYNDROME
The Postural Orthostatic Tachycardia Syndrome (POTS, also
called Chronic Orthostatic Intolerance) affects >500, 000
Americans, the vast majority of whom are premenopausal
women (Robertson, 1999). POTS is characterized by orthostatic
tachycardia without significant hypotension (Raj et al., 2005).
Patients with POTS were previously reported to have altered
baroreflex function (Stewart, 2000), hyperadrenergic activity
(Jacob et al., 1997), or postganglionic sympathetic denerva-
tion and inadequate peripheral vasoconstriction (Stewart and
Weldon, 2000).
Microneurographic studies have shown that POTS patients
have a similar (Bonyhay and Freeman, 2004; Muenter Swift et al.,
2005; Lambert et al., 2008; Fu et al., 2010) or greater (Furlan
et al., 1998) basal MSNA when compared to healthy controls.
All (Muenter Swift et al., 2005; Lambert et al., 2008; Fu et al.,
2010; Baumert et al., 2011) except one (Furlan et al., 1998) studies
reported enhanced MSNA responses during orthostasis in POTS.
Sympathetic baroreflex sensitivity at rest was similar (Bonyhay
and Freeman, 2004; Fu et al., 2010) or even greater (Bonyhay and
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Freeman, 2004; Muenter Swift et al., 2005) in POTS patients than
healthy controls. MSNA responses during static handgrip and the
cold pressor tests were comparable between patients and controls,
even though absolute values of heart rate were consistently higher
in POTS (Fu et al., 2010).
Taken together, these results indicate that modulation of the
sympathetic nervous system by the baroreflex, muscle meta-
boreflex, mechanoreflex, and central command may be intact in
patients with POTS.
SYMPATHETIC NEURAL ACTIVITY IN OBESITY
Obesity is associated with an increased risk of hypertension and
cardiovascular disease in humans. It has been proposed that the
sympathetic nervous system plays a role in obesity, while ethnicity
may alter the relationship between sympathetic activity and obe-
sity (Spraul et al., 1993; Weyer et al., 2000). For example, it was
found that in Pima Indians there was no relationship between
an increase in sympathetic activity and an increase in adiposity,
which may contribute to the low prevalence of hypertension in
this population (Weyer et al., 2000).
Jones et al. found that percent body fat was related to basal
MSNA in both young men and women, but the regression line
was shifted downward in women because of lower levels of MSNA
(Jones et al., 1996a). They also reported that waist-to-thigh ratio
was a better correlate of MSNA than percent body fat; MSNA
and waist-to-thigh ratio were correlated significantly in men but
not as strongly in women. These observations were confirmed
by the study of Tank et al. showing that adjusting for age, waist
circumference, waist-to-hip ratio, and body mass index were
predictive for MSNA in men but not in women (Tank et al.,
2008). These results suggest that abdominal fat is an important
adipose tissue depot regulating MSNA in men, while women
may be protected from sympathetic activation through a hitherto
unknown mechanism (Tank et al., 2008).
Nevertheless, obesity was found to be a major determinant of
sympathetic discharge in women (Abate et al., 2001). Obese nor-
motensive women had a greater basal MSNA than lean women
(Negrao et al., 2001; Ribeiro et al., 2001; Lambert et al., 2007).
However, they had smaller increases in MSNA during static
handgrip and post-exercise circulatory arrest compared with age-
matched lean women, indicating a blunted metaboreflex in obe-
sity (Negrao et al., 2001). Body weight reduction in obese women
resulted in a decrease of blood pressure that was at least partially
caused by a reduction of MSNA (Andersson et al., 1991). It was
also found that weight loss by diet or diet plus exercise training
reduced MSNA during mental stress in obese women (Tonacio
et al., 2006). An improvement in baroreflex control, decreases in
free fatty acids and plasma leptin levels, or an increase in insulin
sensitivity after weight loss may be responsible for the reduction
of MSNA (Tonacio et al., 2006).
Taken together, the sympathetic nervous system plays a role
in obesity in both men and women, but ethnicity may alter
the relationship between sympathetic activity and obesity. Waist-
to-hip ratio correlates with MSNA in men but not in women.
Nevertheless, obese women have a greater level of basal MSNA
compared to lean women. In obese women, weight loss decreases
blood pressure, at least in part, due to a reduction in MSNA.
POLYCYSTIC OVARY SYNDROME
Polycystic ovary syndrome (PCOS) is the most common
endocrine abnormality in women of reproductive age character-
ized by androgen excess and hyperinsulinemia (Schlaich et al.,
2011). It has been proposed that PCOS is a state of sympa-
thetic overactivity (Lara et al., 1993; Sverrisdottir et al., 2008).
Testosterone was found to be a predictor of sympathetic nerve
activity in women with PCOS and increased basal MSNA was
associated with a higher level of testosterone in these patients
(Sverrisdottir et al., 2008). A recent case report in two obese PCOS
patients with hypertension showed that renal denervation exerted
beneficial effects not only on blood pressure control but also
on insulin resistance, renal, and endocrine abnormalities charac-
teristic of PCOS (Schlaich et al., 2011). Three months after the
denervation, basal MSNA decreased in both patients (Schlaich
et al., 2011). Additionally, low-frequency electroacupuncture,
and physical exercise could reduce MSNA and improve clinical
symptoms in women with PCOS (Stener-Victorin et al., 2009).
Thus, patients with PCOS have sympathetic overactivity,
which may be attributable to increased levels of testosterone.
Interventions that can reduce sympathetic activity may improve
symptoms in these patients.
GESTATIONAL HYPERTENSIONAND PREECLAMPSIA
Central sympathetic outflow has been found to increase in
women with normal pregnancies and is even greater in hyperten-
sive pregnant women during late pregnancy (Greenwood et al.,
1998, 2001, 2003) (Figure 3). These findings suggest that sym-
pathetic activation during the latter months of pregnancy may
help to return arterial pressure to non-pregnant levels, and when
the increase in activity is excessive, hypertension may occur. This
FIGURE 3 | Resting mean frequency of single-unit muscle sympathetic
nerve activity (s-MSNA) in the three groups of subjects, NN, NP, and
PIH, expressed as mean (height of columns) and S.E.M. (bars). NN,
normotensive non-pregnancy; NP, normotensive pregnancy; PIH,
pregnancy-induced hypertension. ∗P < 0.05; †P < 0.001. Adapted with
permission from Greenwood et al. (2001).
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notion is supported by the findings of Schobel et al. showing
that preeclamptic women had excessive sympathetic overactivity
(i.e., more than three times as high as that in normotensive preg-
nant women) during late pregnancies (Schobel et al., 1996). It has
been proposed that pregnancy induced sympathetic overactivity
constitutes a precursor of preeclampsia, which is physiologi-
cally compensated for by vasodilating mechanisms, leading to
preeclampsia only when they fail (Fischer et al., 2004). However,
it remains unclear whether sympathetic overactivity is a cause or
consequence of hypertensive disorders in pregnancy.
A previous study showed that preeclampsia was not associated
with greater sympathetic hyperactivity than gestational hyper-
tension, suggesting that any renal impairment in preeclampsia
involves mechanisms that are not solely dependent on sympa-
thetic hyperactivity (Greenwood et al., 2003). In patients with
preeclampsia, epidural anesthesia reduces uterine artery vascular
resistance (Ramos-Santos et al., 1991; Ginosar et al., 2009).
These results indicate that sympathetic vasoconstriction may be
specifically augmented in preeclamptic women. However, it is
completely unknown whether women with gestational hyper-
tension and preeclampsia have excessive sympathetic activation
and/or enhanced sympathetic vasoconstriction early on during
pregnancy, or whether sympathetic overactivity occurs only at
term, providing the substrate for both of these complications.
Taken together, both gestational hypertension and preeclamp-
sia are associated with sympathetic overactivity. However,
whether sympathetic overactivity is a cause or consequence of
hypertensive disorders during pregnancy remains to be deter-
mined.
ESSENTIAL HYPERTENSION, HEART FAILURE AND MYOCARDIAL
INFARCTION
Women with chronic essential hypertension have increased levels
of basal MSNA compared with their normotensive counterparts,
and MSNA is significantly related to blood pressure (Lambert
et al., 2007). However, young andmiddle-aged (mean age 51 years
old) female hypertensive patients have a lower level of sympa-
thetic activity compared to aged-matched male patients (Hogarth
et al., 2007). Postmenopausal women (mean age 58 years old)
continue to have a lower level of basal MSNA than similarly aged
men even after the development of chronic essential hypertension
(Hogarth et al., 2008). Whether older (i.e.,≥ 65 years old) and/or
very old (i.e., ≥ 80 years old) hypertensive women have a similar
or even greater MSNA compared with age-matched hypertensive
men needs to be investigated.
Recent studies have shown that basal MSNA is not clearly
different between middle-aged female and male patients with
chronic heart failure (Antunes-Correa et al., 2010). The bene-
fits of exercise training on neurovascular control and functional
capacity in patients with heart failure are independent of sex
(Antunes-Correa et al., 2010).
Sympathetic activation occurs following acute myocardial
infarction (Karlsberg et al., 1981; McAlpine et al., 1988; Graham
et al., 2002; Hogarth et al., 2009) and is related to the extent
of myocardial damage (McAlpine et al., 1988; Hogarth et al.,
2009). Following uncomplicated acute myocardial infarction,
women were found to develop a relatively greater magnitude of
sympathetic activation lasting until its resolution at 9 months.
This is consistent with reports of their worse prognosis observed
during this time period with important potential clinical implica-
tions (Hogarth et al., 2009).
Taken together, sympathetic activation is associated with
hypertension and cardiovascular disease in both women andmen.
Sex may affect the degree of sympathetic activation and the prog-
nosis of the disease. Such information may be useful for selection
of treatment for female patients.
SUMMARY
Previous and recent microneurographic studies suggest that sym-
pathetic neural control may be affected by physiological changes
such as age, race, fluctuations of female sex hormones during
the menstrual cycle, use of oral contraceptives, and pregnancy. In
additional, pathophysiological conditions such as syncope, POTS,
obesity, PCOS, hypertensive pregnancy, essential hypertension,
heart failure, and myocardial infarction may also affect sympa-
thetic neural control in women. In many medical conditions,
excessive sympathetic activation is a primary or secondary under-
lying cause regardless of sex and age. In some situations, for
example, syncope, sympathetic inhibition or withdrawal may be
one of the determinant factors. Results obtained from these stud-
ies provide valuable information regarding women’s health and
disease, which has significant clinical implications and is relevant
to public health.
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